研究报告

短双歧杆菌对Aβ1-42导致的阿尔兹海默症小鼠肠道菌群及代谢物的影响

  • 朱广素 ,
  • 赵建新 ,
  • 张灏 ,
  • 陈卫 ,
  • 王刚
展开
  • (江南大学 食品学院,江苏 无锡,214122)
博士(王刚教授为通信作者,E-mail:wanggang@jiangnan.edu.cn)

收稿日期: 2021-06-04

  修回日期: 2021-06-28

  网络出版日期: 2022-03-04

基金资助

国家自然科学基金面上项目(31972052)

Effects of Bifidobacterium breve strains on gut microbiota and metabolites in Aβ-injected mice

  • ZHU Guangsu ,
  • ZHAO Jianxin ,
  • ZHANG Hao ,
  • CHEN Wei ,
  • WANG Gang
Expand
  • (School of Food Science and Technology,Jiangnan University,Wuxi 214122,China)

Received date: 2021-06-04

  Revised date: 2021-06-28

  Online published: 2022-03-04

摘要

为分析2株不同来源的短双歧杆菌对脑部微注射Aβ1-42蛋白导致的阿尔兹海默症小鼠肠道菌群及其代谢物的影响,给小鼠海马区注射Aβ1-42蛋白建立阿尔兹海默症小鼠模型,连续灌胃6周2株不同来源的短双歧杆菌,收集小鼠粪便,采用Illumina MiSeq高通量测序技术分析菌群的多样性及物种组成,并采用GC-MS技术检测小鼠粪便中短链脂肪酸的含量。菌群多样性分析发现,Aβ1-42蛋白注射改变了小鼠的菌群多样性及物种结构,灌胃短双歧杆菌可一定程度上改善菌群紊乱。进一步在属水平和种水平分析各组菌群差异,发现灌胃短双歧杆菌MY显著提高了大鼠肠道中产短链脂肪酸菌Coprococcus spp.、Lactobacillus reuteriAkkermansia muciniphila的相对丰度,且有效调控了肠道内3种短链脂肪酸的水平。短双歧杆菌MY可能通过调节肠道菌群及其代谢物短链脂肪酸的水平缓解小鼠的认知障碍。

本文引用格式

朱广素 , 赵建新 , 张灏 , 陈卫 , 王刚 . 短双歧杆菌对Aβ1-42导致的阿尔兹海默症小鼠肠道菌群及代谢物的影响[J]. 食品与发酵工业, 2022 , 48(3) : 70 -77 . DOI: 10.13995/j.cnki.11-1802/ts.028210

Abstract

To evaluate the effects of Bifidobacterium breve from different sources on intestinal microflora and its metabolites in mice with Alzheimer's diseases (AD) induced by Aβ1-42 injection, an animal model by injecting intrahippocampal Aβ1-42 to mice was established, and two B. breve strains were separately administered to mice for 6 week. The microbial diversity and composition were measured. The microbial diversity and composition were significantly changed after Aβ1-42 injection. Notably, B. breve supplementation displayed various effects on the recovery of gut microbiota dysbiosis. Metagenomic analysis showed that B. breve MY administration dramatically increased the relative abundance of Coprococcus spp., Lactobacillus reuteri and Akkermansia muciniphila at genus and species level. In addition, GC-MS analysis found that supplementation with MY markedly modulated the concentrations of short-chain fatty acids (SCFAs). B. breve MY may delay the progression of AD by modulating the gut microbiota and SCFAs.

参考文献

[1] SCHELTENS P,BLENNOW K,BRETELER M M B,et al.Alzheimer's disease[J].The Lancet,2016,388(10043):505-517.
[2] CHOI S H,BYLYKBASHI E,CHATILA Z K,et al.Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model[J].Science,2018,361(6406).DOI:10.1126/science.aan8821.
[3] CRYAN J F,O′RIORDAN K J,SANDHU K,et al.The gut microbiome in neurological disorders[J].The Lancet Neurology,2020,19(2):179-194.
[4] BERCIK P,DENOU E,COLLINS J,et al.The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice[J].Gastroenterology,2011,141(2):599-609.e3.
[5] CRYAN J F,O′RIORDAN K J,COWAN C S M,et al.The microbiota-gut-brain axis[J].Physiological Reviews,2019,99(4):1 877-2 013.
[6] ZHUANG Z Q,SHEN L L,LI W W,et al.Gut microbiota is altered in patients with Alzheimer's disease[J].Journal of Alzheimer's Disease,2018,63(4):1 337-1 346.
[7] LIU P,WU L,PENG G P,et al.Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort[J].Brain,Behavior,and Immunity,2019,80:633-643.
[8] VOGT N M,KERBY R L,DILL-MCFARLAND K A,et al.Gut microbiome alterations in Alzheimer's disease[J].Scientific Reports,2017,7:13537.
[9] KOH A,DE VADDER F,KOVATCHEVA-DATCHARY P,et al.From dietary fiber to host physiology:Short-chain fatty acids as key bacterial metabolites[J].Cell,2016,165(6):1 332-1 345.
[10] ZHAN X H,STAMOVA B,JIN L W,et al.Gram-negative bacterial molecules associate with Alzheimer disease pathology[J].Neurology,2016,87(22):2 324-2 332.
[11] HWANG Y H,PARK S,PAIK J W,et al.Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment:A 12-week,multi-center,randomized,double-blind,placebo-controlled clinical trial[J].Nutrients,2019,11(2):305.
[12] WANG X Y,SUN G Q,FENG T,et al.Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression[J].Cell Research,2019,29(10):787-803.
[13] DINAN T G,STANTON C,CRYAN J F.Psychobiotics:A novel class of psychotropic[J].Biological Psychiatry,2013,74(10):720-726.
[14] DINAN T G,CRYAN J F.Brain-gut-microbiota axis—mood,metabolism and behaviour[J].Nature Reviews Gastroenterology & Hepatology,2017,14(2):69-70.
[15] JAN A,HARTLEY D M,LASHUEL H A.Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research[J].Nature Protocols,2010,5(6):1 186-1 209.
[16] LOURENCO M V,FROZZA R L,DE FREITAS G B,et al.Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models[J].Nature Medicine,2019,25(1):165-175.
[17] MAO B Y,LI D Y,ZHAO J X,et al.Metagenomic insights into the effects of fructo-oligosaccharides (FOS) on the composition of fecal microbiota in mice[J].Journal of Agricultural and Food Chemistry,2015,63(3):856-863.
[18] CHONG J,LIU P,ZHOU G Y,et al.Using MicrobiomeAnalyst for comprehensive statistical,functional,and meta-analysis of microbiome data[J].Nature Protocols,2020,15(3):799-821.
[19] ZHU G S,MA F L,WANG G,et al.Bifidobacteria attenuate the development of metabolic disorders,with inter-and intra-species differences[J].Food & Function,2018,9(6):3 509-3 522.
[20] BALLARD C,GAUTHIER S,CORBETT A,et al.Alzheimer's disease[J].The Lancet,2011,377(9770):1 019-1 031.
[21] HENEKA M T,CARSON M J,EL KHOURY J,et al.Neuroinflammation in Alzheimer's disease[J].The Lancet.Neurology,2015,14(4):388-405.
[22] SAMPSON T R,DEBELIUS J W,THRON T,et al.Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease[J].Cell,2016,167(6):1 469-1 480.
[23] FACCHINETTI R,BRONZUOLI M R,SCUDERI C.An animal model of alzheimer disease based on the intrahippocampal injection of Amyloid β-Peptide (1-42)[J].Methods in Molecular Biology,2018,1 727:343-352.
[24] TIAN P J,ZOU R Y,SONG L H,et al.Ingestion of Bifidobacterium longum subspecies infantis strain CCFM687 regulated emotional behavior and the central BDNF pathway in chronic stress-induced depressive mice through reshaping the gut microbiota[J].Food & Function,2019,10(11):7 588-7 598.
[25] KOBAYASHI Y,KINOSHITA T,MATSUMOTO A,et al.Bifidobacterium breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment:An open-label,single-arm study[J].The Journal of Prevention of Alzheimer's Disease,2019,6(1):70-75.
[26] AKBARI E,ASEMI Z,DANESHVAR KAKHAKI R,et al.Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease:A randomized,double-blind and controlled trial[J].Frontiers in Aging Neuroscience,2016,8:256.
[27] TIAN P J,O′RIORDAN K J,LEE Y K,et al.Towards a psychobiotic therapy for depression:Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice[J].Neurobiology of Stress,2020,12:100216.
[28] BUFFINGTON S A,DI PRISCO G V,AUCHTUNG T A,et al.Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring[J].Cell,2016,165(7):1 762-1 775.
[29] FUNG T C,OLSON C A,HSIAO E Y.Interactions between the microbiota,immune and nervous systems in health and disease[J].Nature Neuroscience,2017,20(2):145-155.
文章导航

/